Construction work of a vaccine production unit has started at Andharua in Bhubaneshwar and a target has been set to commence production of Covaxin by June 2022, the Odisha government has announced. The vaccine unit being set up through Bharat Biotech International Ltd (BBIL) will produce around 10 types of advanced vaccines, including that for coronavirus and malaria, as per a release. The construction of the vaccine production unit because of IDCO s smooth land allotment process and ease of doing business reforms , stated the release further. The required statutory clearances and permissions have also been granted for setting up the unit. It was informed after a state-level Bio-Tech implementation committee meeting held virtually under the chairmanship of Chief Secretary Suresh Chandra Mahapatra from Lokseva Bhawan wherein Secretary Science and Technology Manoj Mishra outlined the administrative and financial issues for discussion.
Odisha govt, Bharat Biotech to set up vaccine manufacturing unit in Bhubaneswar
Odisha govt, Bharat Biotech to set up vaccine manufacturing unit in Bhubaneswar
The construction of the vaccine production unit has already started at Andharua in Odisha s Bhubaneswar even as the state government aims to commence the Covaxin production by June 2022.
advertisement
UPDATED: May 7, 2021 11:24 IST
The Odisha government aims to begin production of Covaxin in Bhubaneswar soon. (Image for representaation: PTI)
The Odisha government aims to begin production of Bharat Biotech vaccine Covaxin in the state capital Bhubaneswar by June 2022. The construction of the vaccine production unit has already started at Andharua in Bhubaneswar and a target has been set to commence the production of Covaxin by June 2022.